MedPath

Role of the nicotinic cholingergic System in top down and bottom up control of attentio

Not Applicable
Recruiting
Conditions
healthy volunteers
Registration Number
DRKS00004529
Lead Sponsor
Institut für Psychologie, Universität Oldenburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

MR compatible, healthy

Exclusion Criteria

neurological or psychiatric disease, metal in body, intake of drugs, smoker, left handed

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison nicotine-placebo. It is one measurement after acute application of the drug. Primary endpoint in fMRI is a significant change in BOLD activity in parietal cortex, on the behavioural side it is a significant change in reaction times in the experimental paradigm.
Secondary Outcome Measures
NameTimeMethod
Comparison nicotine-placebo. It is one measurement after acute application of the drug. Secondary endpoint in fMRI is a significant change in BOLD activity in frontal and temporal cortex, on the behavioural side it is a significant change in accuracy and variability of reaction times in the experimental paradigm.
© Copyright 2025. All Rights Reserved by MedPath